Informed-money record

APLS · Apellis Pharmaceuticals, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

0

Bearish filings

46

Named actors

9

Disclosed $ (bull / bear)

$0 / $14.2M

Recent disclosures

25 of 46 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-04-29Chief Medical Officer Baumal CarolinegiftedSEC ↗
2026-04-17Chief Financial Officer Sullivan Timothy EugenegiftedSEC ↗
2026-02-11Chief Business & Strat Officer DeLong Mark Jeffreysold$8KSEC ↗
2026-01-22General Counsel Watson David O.sold$171KSEC ↗
2026-01-22Chief Financial Officer Sullivan Timothy Eugenesold$224KSEC ↗
2026-01-22Chief Technical Officer Nicholson Nursold$168KSEC ↗
2026-01-22Chief Executive Officer Francois Cedricsold$592KSEC ↗
2026-01-22Chief Scientific Officer Deschatelets Pascalsold$129KSEC ↗
2026-01-22Chief Business & Strat Officer DeLong Mark Jeffreysold$73KSEC ↗
2026-01-22VP/Chief Accounting Officer Chopas James Georgesold$45KSEC ↗
2026-01-22Chief Medical Officer Baumal Carolinesold$61KSEC ↗
2026-01-20General Counsel Watson David O.sold$49KSEC ↗
2026-01-20Chief Financial Officer Sullivan Timothy Eugenesold$57KSEC ↗
2026-01-20Chief Technical Officer Nicholson Nursold$44KSEC ↗
2026-01-20Chief Executive Officer Francois Cedricsold$162KSEC ↗
2026-01-20Chief Scientific Officer Deschatelets Pascalsold$18KSEC ↗
2026-01-20Chief Business & Strat Officer DeLong Mark Jeffreysold$26KSEC ↗
2026-01-20VP/Chief Accounting Officer Chopas James Georgesold$14KSEC ↗
2026-01-20Chief Medical Officer Baumal Carolinesold$37KSEC ↗
2026-01-13General Counsel Watson David O.sold$128KSEC ↗
2026-01-13Chief Financial Officer Sullivan Timothy Eugenesold$86KSEC ↗
2026-01-13Chief Technical Officer Nicholson Nursold$58KSEC ↗
2026-01-13Chief Executive Officer Francois Cedricsold$226KSEC ↗
2026-01-13Chief Scientific Officer Deschatelets Pascalsold$51KSEC ↗
2026-01-13Chief Business & Strat Officer DeLong Mark Jeffreysold$39KSEC ↗

21 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals